ZFYVE27 and systemic lupus erythematosus: The LV-protrudin group presented fewer SLEs (LV-GFP, 11.57 ± 1.718; LV-Protrudin, 5.429 ± 1.718; P = 2.233×10−5) and had a shorter duration of SLEs (LV-GFP, 23.68 ± 3.442; LV-Protrudin, 14.45 ± 3.809; P = 4.676×10−4) and a longer SLE interval time (LV-GFP, 142.1 ± 24.5; LV-Protrudin, 342.9 ± 89.06; P = 9.132×10−5) than the LV-GFP group (LV-GFP, n = 7; LV-Protrudin, n = 7) (Fig. 3c–e).